| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |